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Abstract
Background: The metabolic syndrome (MetS) has been known as partly heritable, while the number of genetic studies on
MetS and metabolic-related traits among Chinese elderly was limited.
Methods: A cross-sectional analysis was performed among 2 014 aged participants from September 2009 to June 2010 in
Beijing, China. An additional longitudinal study was carried out among the same study population from 2001 to 2010.
Biochemical profile and anthropometric parameters of all the participants were measured. The associations of 23 SNPs
located within 17 candidate genes (MTHFR, PPARc, LPL, INSIG, TCF7L2, FTO, KCNJ11, JAZF1, CDKN2A/B, ADIPOQ, WFS1,
CDKAL1, IGF2BP2, KCNQ1, MTNR1B, IRS1, ACE) with overweight and obesity, diabetes, metabolic phenotypes, and MetS were
examined in both studies.
Results: In this Chinese elderly population, prevalence of overweight, central obesity, diabetes, dyslipidemia, hypertension,
and MetS were 48.3%, 71.0%, 32.4%, 75.7%, 68.3% and 54.5%, respectively. In the cross-sectional analyses, no SNP was
found to be associated with MetS. Genotype TT of SNP rs4402960 within the gene IGF2BP2 was associated with overweight
(odds ratio (OR) =0.479, 95% confidence interval (CI): 0.316-0.724, p=0.001) and genotype CA of SNP rs1801131 within the
gene MTHFR was associated with hypertension (OR=1.560, 95% CI: 1.194–2.240, p=0.001). However, these associations
were not observed in the longitudinal analyses.
Conclusions: The associations of SNP rs4402960 with overweight as well as the association of SNP rs1801131 with
hypertension were found to be statistically significant. No SNP was identified to be associated with MetS in our study with
statistical significance.
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Introduction
The metabolic syndrome (MetS) is recognized as a complex
disorder of central obesity, high blood pressure, high plasma
glucose, and dyslipidemia [1]. People affected by MetS are at an
increased risk of severe health complications, such as type 2
diabetes mellitus (T2DM) and cardiovascular disease (CVD) [2,3].
Heritability estimates for MetS range from 10% to 30% [4–6],
indicating that MetS is partly heritable. Knowledge of exact
genetic factors underlying MetS development may help to explain
why the traits of MetS frequently coexist within individuals.
Single-nucleotide polymorphisms (SNPs) are widely present in
human DNA sequences and some are considered to be disease-
related. In recent years, genome-wide association studies (GWAS)
have identified numerous candidate SNPs that are unequivocally
associated with metabolic-related traits, including obesity, diabe-
tes, hypertension, and dyslipidemia. However, most of these SNPs
were identified and studied in young-age populations, and the
number of previous genetic studies in aged participants was
limited. Aged participants are expected to have more cumulative
environmental exposure and thus be more likely to be affected by
gene-environment interaction than younger people. Whether the
genetic effects of metabolic-related traits observed in younger
groups can be replicated in elders has not be well studied.
In order to detect genes underlying the development of
metabolic-related traits, we cross-sectionally analyzed 23 SNPs
located in 17 genes among a Chinese elderly population in Beijing.
These SNPs include: 1) methylenetetrahydrofolate reductase
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(PPARc); 3) insulin induced gene 2 (INSIG2); 4) transcription factor
7-like 2 (TCF7L2); 5) fat mass and obesity associated (FTO); 6)
potassium inwardly-rectifying channel, subfamily J, member 11
(KCNJ11); 7) JAZF zinc finger 1 (JAZF1); 8) cyclin-dependent
kinase inhibitor 2A (CDKN2A); 9) adiponectin, C1Q, and collagen
domain containing (ADIPOQ); 10) Wolfram syndrome 1 (WFS1);
11) CDK5 regulatory subunit associated protein 1-like 1
(CDKAL1); 12) insulin-like growth factor 2 mRNA binding protein
2( IGF2BP2); 13) potassium voltage-gated channel, KQT-like
subfamily, member 1 (KCNQ1); 14) melatonin receptor 1B
(MTNR1B); 15) insulin receptor substrate 1 (IRS1); 16) angiotensin
I converting enzyme (ACE); and 17) lipoprotein lipase (LPL). We
further extracted data of 742 participants from the same
population to investigate whether individuals that were persistently
affected by a particular condition were under a strong influence
from markers of genetic susceptibility, and whether individuals
that were persistently unaffected by that condition were influenced
by the protective effects of certain genes. This subpopulation had
completed records from 2001 to 2010, and allowed us to conduct a
longitudinal analysis to test our hypotheses.
Analyses were carried out in two stages: i) a cross-sectional study
on selected metabolic-related traits and MetS, and ii) a 10-year
longitudinal study on persistent metabolic-related traits and MetS.
Materials and Methods
Study participants and phenotype definitions
Subjects and study design. Study participants were from
Wanshoulu Community in the Haidian District, Beijing, China.
This area represents the local geographic and economic charac-
teristics. Sampling and research methods were described elsewhere
[7]. From 2009 to 2010, a total of 2 162 participants were
randomly selected based on a 2-stage stratified sampling approach.
After excluding subjects with incomplete data and those with age
,60 years old, 2 014 (93.2%) subjects were included in the cross-
sectional analyses. Furthermore, 742 of these 2 014participants
(35%) had completed records back to 2001, which allowed us to
conduct a longitudinal study. Subjects in the longitudinal study
were grouped based on persistency with metabolic-related traits.
Data collection. Potential participants were invited to a
community clinic by letters or telephone calls, and were
interviewed with structured questionnaires that covered education
level, leisure time physical activity, smoking status, alcohol
consumption, family disease history, and individual disease history.
Physical examination. Weight, height, waist circumference
(WC), hip circumference, and resting blood pressure were
measured according to a standard protocol. Weight was measured
in kilograms (with heavy clothes removed and 1 kg deducted from
measured weight to account for remaining garments), height was
measured in meters (without shoes), and WC was measured in a
standing position with a soft tape midway between the lowest rib
and the iliac crest. Two measures of resting blood pressure were
obtained from the right arm in a sitting position after 30 minutes
of rest, with a 5 minutes interval, and averaged. Plasma levels of
lipids and glucose were measured using overnight fasting blood
specimens. Fasting plasma glucose (FPG) was measured using a
modified hexokinase enzymatic method. Concentrations of total
cholesterol (TC), high-density lipoprotein cholesterol (HDL-c),
low-density lipoprotein cholesterol (LDL-c), and triglycerides (TG)
were assessed enzymatically with commercially available reagents
following the manufacturer’s protocol.
All physical examinations and interviews were carried out by
trained nurses and physicians.
Definitions of overweight and metabolic-related
traits. BMI was calculated as body weight in kilograms divided
by the square of height in meters. The World Health Organiza-
tion’s definitions of overweight (BMI $25 kg/m
2) and obesity
(BMI $30 kg/m
2) and central obesity (waist circumference $
90 cm in men and $80 cm in women) in Asians were used [8,9].
Dyslipidemia was defined as TC $5.8 mmol/L (220 mg/dL), or
TG $1.7 mmol/L (150 mg/dL), or HDL-c ,1.0 mmol/L
(40 mg/dL) in men (,1.3 mmol/L (50 mg/dL) in women), or
under treatment of dyslipidemia. T2DM was defined by history or
1999 World Health Organization’s criteria [10]: FPG concentra-
tions $7.0 mmol/L (126 mg/dL) or OGTT (2h) $11.1 mmol/L.
Hypertension was defined as systolic blood pressure (SBP) $
140 mmHg, or diastolic blood pressure (DBP) $90 mmHg, or by
history.
Definition of MetS. MetS status was defined according to
the modified International Diabetes Federation (IDF) definition
[8]. To have MetS, participants must have central obesity and
with any 2 of the following 4 additional factors: 1) high blood
pressure (SBP $130 mmHg, or DBP $85 mmHg, or under
treatment); 2) hypertriglyceridemia (TG $1.7 mmol/L); 3) low
HDL-c (HDL-c ,1.0 mmol/L in men or ,1.3 mmol/L in
women); and 4) hyperglycemia (FPG $5.6 mmol/L).
Ethics Statemen. The study was approved by the Commit-
tee for Medical Ethics of the Chinese PLA General Hospital, and
signed informed consents were obtained from all participants.
Genotyping. DNA was extracted from the whole peripheral
blood sample by the standard proteinase K-phenol-chloroform
method. The laboratory staffs were blinded to the identities of the
subjects and their MetS status.
The candidate SNPs were selected based on GWAS studies
published before August 2010. SNPs identified among Asian
populations were considered first [11–26]. A total of 23 SNPs from
17 genes that have been confirmed by most of the above studies
with minor allele frequency (MAF) .0.1 were chosen for our
analyses. The information for reference sequences of the SNPs
were searched from the dpSNP database on the National Center
for Biotechnology Information (NCBI) website (http://www.ncbi.
nlm.nih.gov/snp/).
Genotyping of candidate SNPs was performed using the
MassARRAY system. After polymerase chain reaction (PCR)
amplification, primer extension products were analyzed by chip-
based Matrix-Assisted Laser Desorption/Ionization Time of Flight
Mass Spectrometry (MALDI-TOF MS). Extension primers were
designed to extend beyond the SNP site by one or two bases using
the software Assay Design 3.1. Primer extension as well as PCR
were performed according to manufacturer’s standard protocols.
All PCR amplification procedures were carried out with PCR
system. After desalting, approximately 10 nl reaction product were
loaded onto a 384-well SpectroCHIP that has been preloaded with
patches of crystalline matrix. As quality control measures, four
negative controls (water without DNA) were included to detect
contamination in each SpectroCHIP. The SpectroCHIPs were
analyzed in the fully automated mode with the MALDI-TOF
MassARRAY system. SpectroTYPER 4.0 software performs
genotype calling automatically using a set of digital filters
optimized for mass spectra of oligonucleotides.
The average success rate of genotyping for each polymorphism
was 99.5%.
Statistical analysis. Continuous variables were expressed as
mean 6 standard deviation (SD). Characteristics of study
participants were compared using unpaired Student’s t-test or
Pearson’s Chi-square test (or Fisher’s exact test) for continuous
Genetic Effects on Metabolism in Chinese Elders
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Weinberg equilibrium (HWE) and linkage disequilibrium (LD)
were performed with HAPLOVIEW software version 4.2 (Doc-
ument3http://www.broadinstitute.org/haploview). We used mul-
tivariable logistic regression models to analyze the associations of
candidate SNPs genotypes with MetS and metablic-related traits.
Odds ratios (ORs) and 95% confidence intervals (CIs) were
reported.
All statistical analyses were performed using SPSS version 16.0
statistic package for windows. All statistical tests were based on 2-
sided test, and a p-value of ,0.05 was considered to be statistically
significant. Multiple testing was adjusted using the Bonferroni
method when necessary, and a p-value of ,0.003 was considered
as statistically significant.
Results
Characteristics
We included 2,014 subjects in the cross-sectional study and 742
subjects in the longitudinal study. The prevalence of overweight,
central obesity, T2DM, dyslipidemia, hypertension, and MetS in
the cross-sectional study were 48.3%, 71.0%, 32.4%, 75.7%,
68.3% and 54.5%, respectively. The population characteristics of
the subjects stratified by sex are shown in Table 1. In both studies,
women were found to be younger than men and have lower WC,
lower DBP, higher SBP, higher serum TC, higher serum HDL-c,
and higher serum TG. Women were less likely to be drinker,
current smoker, and to spend less time on exercise than men.
Of the 23 SNPs, SNP rs328 in the gene LPL was found to be
departed from Hardy-Weinberg Equilibrium in the control group
(data not shown) and was excluded from all analyses. Strong LD
was observed between rs8050136 and rs9939609 in FTO gene
(r
2=0.99), between rs4506565 and rs7903146 in TCF7L2 gene
(r
2=0.98), and between rs4712523 and rs7754840 in CDKAL1
gene (r
2=0.94). However, LD was low between rs1387153 and
rs10830963 in MTNR1B gene (r
2=0.67), and between rs1801131
and rs1801133 in MTHFR gene (r
2=0.18).
Associations of SNPs with metabolic-related traits
We used multivariable logistic regression models to examine the
associations of candidate SNPs with MetS and metabolic-related
traits, adjusted for age, sex, BMI, and lifestyle factors (leisure time
physical activity, alcohol consumption, smoking status, and
educational level). In cross-sectional analyses, genotype TT of
rs4402960 located within gene IGF2BP2 was associated with
overweight (OR=0.479, 95% CI: 0.316–0.724, p=0.001) and
genotype CA of rs1801131 in gene MTHFR was associated with
hypertension (OR=1.560, 95% CI: 1.194–2.240, p=0.001) after
adjusting for multiple testing. However, these statistically signif-
icant associations were not observed in the longitudinal analyses
(Table 2).
The associations of SNP rs4402960 and SNP rs2237892 with
overweight were similar in our study and were both identified to
be associated with diabetes before. That suggested a potential
gene-gene interaction of gene IGF2BP2 with KCNQ1 on over-
weight in our study. So we examined this interaction using a
logistic regression model, however the interaction was not
statistically significant (data not shown).
Associations of SNPs with MetS
We found no statistically significant association of SNPs with
MetS in both analyses.
Discussion
The associations of the variations of these candidate SNPs with
obesity and various traits of the MetS have been examined in
many populations. However, to our knowledge, this is the first
study to investigate so many SNPs among a large elderly Chinese
population. Elderly subjects are expected to have higher cumu-
lative exposure to environmental risk factors and thus be more
likely to be affected by gene-environment interaction than younger
people. It is unknown whether the environmental influences would
dilute the contribution of susceptible genotypes to metabolic-
related traits or, rather, would make the phenotypes conferred by
the susceptible genotypes more likely to show up [27]. Therefore,
it is meaningful to investigate these genetic associations among
aged participants.
We carried out two observational studies among Chinese elders
to explore associations of a total of 22 SNPs located within 16
genes with MetS and metabolic-related traits, including over-
weight and obesity, T2DM, hypertension and dyslipidemia. In the
cross-sectional analyses, statistically significant associations of the
SNP rs4402960 located in gene IGF2BP2 with overweight and the
SNP rs1801131 in gene MTHFR with hypertension were observed
in our model 1 adjusting for age, sex, life style factors (leisure time
physical activity, alcohol consumption, smoking status, and
educational level). Further inclusion of BMI in the model 2 did
not change the statistical significance and the magnitude of the
association, indicating that the association may be independent of
BMI. The association of rs1801131 with hypertension was not
statistically significant in the longitudinal analyses, but this is
possibly because of the low statistical power due to a small sample
size.
We also depicted the functional associations between some
SNPs and phenotypes (Fig.1). IGF2 is a polypeptide growth factor
that plays an important role in growth and development, and it
stimulates insulin action. IGF2BP1 binds to the leading 3 mRNA
in the 59-UTR of the IGF2 gene to regulate IGF2 translation [28].
However, the biological function of IGF2BP2 is not well-studied.
Previous studies have shown that the T allele of the SNP
rs4402960 was a risk factor for diabetes [29]. In the present study,
we found no statistically significant association between rs4402960
and diabetes. However, variant allele T was negatively associated
with overweight. To our knowledge, this is the first study that
reports such a protective association of this SNP with overweight.
In the study by Xia Li et al, rs11705701, a SNP in strong LD with
rs4402960, was identified to be associated with percent body fat in
Mexican Americans [30]. In addition, SNP rs2237892 located
within gene KCNQ1 was found to be associated with both
overweight and obesity and diabetes at first [19,31,32]. Variant
allele T of rs2237892 was associated with a higher prevalence of
overwight, but was with a lower prevalence of diabetes in our
study, which was consistent with previous studies [31,33–35].
Biologically, KCNQ1 is a gene encoding the poreforming subunit of
a voltage-gated K+ channel that plays a key role in the
repolarization of the cardiac action potential as well as water
and salt transportation in the beta cells [19,32,36]. KV-channel
knock-out in rat islets as well as pharmacological inhibition of KV-
channels in rat beta cells have been reported to enhance glucose-
stimulated insulin secretion [37–39]. Meanwhile, IGF2BP2 were
also associated with reductions in first-phase insulin secretion in
some studies [40,41]. Moreover, both SNPs were located at 11p15
of chromosome, variants of which were confirmed to be associated
with the Beckwith-Wiedemann syndrome (BWS). The associations
mentioned above suggested a possible interaction between
rs4402960 and rs2237892 for overweight and obesity in our
Genetic Effects on Metabolism in Chinese Elders
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significance. Further studies of these two SNPs are necessary.
INSIG1 and INSIG2 play important roles in regulating
cholesterol or TG synthesis, mainly in the liver. rs7566605, which
is located 10 kb upstream of INSIG2, was reported to have the
strongest association with obesity among 86 604 SNPs [42].
Biological functional evidence depicted the INSIG2 gene from the
very start as a candidate gene for obesity as being involved in the
reversed cholesterol transport by an interaction with sterol
regulatory element-binding proteins (SREBPs) [43], which are
transcription factors that activate the synthesis of cholesterol and
fatty acids in the liver and other organs [44]. Even so, studies on
the SNP-obesity associations reported inconsistent results [45–52].
In the present study, we did not obtain statistically significant
association between SNP rs7566605 and overweight and obesity.
The relationship between rs7566605 with dyslipidemia was also
not statistically significant after correcting for multiple testing. A
Japanese population study reported that rs7566605 was associated
with dyslipidemia in heterogeneous co-dominant genetic model,
which known as the first report to identify this associations [53]. So
we analyzed the relationship between SNP rs7566605 and
dyslipidemia in different heterogeneous models, adjusting for
multiple covariates. We found subjects with the CG heterozygote
had 1.368-fold (95% CI: 1.107–1.192) increased in OR for
dyslipidemia compared to the combination of genotype GG and
genotype CC (data not shown). This result also suggested a
heterogeneous co-dominant genetic model in our study.
MTHFR gene showed a strong association with hypertension in
our cross-sectional analyses, and OR was similar to the result of a
previous meta-analysis among Asian population [54]. A common
C to T transition at nucleotide 677 (C677T, rs1801133) and A to
C transition at nucleotide 1298 (A1298C, rs1801131) of the gene
coding sequence, have been shown to be the most frequent genetic
causes for mild hyperhomocysteinemia [55,56]. High plasma
concentration of homocysteine may predispose individuals to
Table 1. Characteristics of study participants of both cross-sectional and longitudinal gene associated studies among a Chinese
Aged Population Sample.
Cross-sectional Study (2 014) Longitudinal Study (742)
Variables Men Women p Men Women p
N 798 1,216 279 463
Age (years) 72.3766.91 70.3566.20 ,0.001* 77.1764.63 75.0264.72 ,0.001*
BMI (kg/m
2) 25.0063.03 25.0363.63 0.848 25.2662.87 25.6963.31 0.061
Waist circumference (cm) 91.3468.40 84.3468.91 ,0.001* 89.5068.31 85.4068.20 ,0.001*
Smoke, N (%) ,0.001* ,0.001*
Never smoker, 369 (46.2) 1104 (90.8) 131 (47.0) 410 (88.6)
Former smoker 253 (31.7) 61 (5.0) 81 (29.0) 19 (4.1)
Current smoker 176 (22.1) 51 (4.2) 67 (24.0) 34 (7.3)
Current drinker, N (%) 377 (47.2) 100 (8.2) ,0.001* 80 (28.7) 29 (6.3) ,0.001*
Education level, N (%) ,0.001* ,0.001*
Primary school or lower 144 (18.0) 420 (34.5) 68 (24.4) 222 (47.9)
Middle school or High school 279 (35.0) 536 (44.1) 107 (38.4) 170 (36.7)
University or above 375 (47.0) 250 (21.4) 104 (37.3) 71 (15.3)
Physical activity, N (%) 0.122 ,0.001
, one hour per day 99 (12.4) 184 (15.1) 25 (9.0) 86 (18.6)
1 - 3 hours per day 629 (78.8) 911 (74.9) 220 (78.9) 350 (75.8)
$ 4 hours per day 70 (8.8) 121 (10.0) 34 (12.2) 26 (5.6)
Family diseases history, N (%)
Coronary heart disease 181 (22.7) 270 (22.2) 0.801 52 (18.8) 76 (16.4) 0.412
Diabetes 126 (15.8) 237 (19.5) 0.035* 20 (7.2) 39 (8.4) 0.559
Hypertension 282 (35.3) 563 (46.3) ,0.001* 91 (32.9) 192 (41.5) 0.020*
SBP, mmHg 136.72617.8 140.60620.8 ,0.001* 133.6617.9 135.57621.6 0.182
DBP, mmHg 78.4069.6 76.7269.9 ,0.001* 78.4769.6 77.84611.1 0.430
FPG, mmol/L 6.1261.5 6.1061.7 0.771 5.8961.5 6.0161.7 0.324
Serum HDL-c, mmol/L 1.3160.3 1.4760.3 ,0.001* 1.2660.3 1.4160.3 ,0.001*
Serum TG, mmol/L 1.5260.8 1.7860.9 ,0.001* 1.3960.9 1.7161.2 ,0.001*
Serum TC, mmol/L 4.9560.9 5.5061.0 ,0.001* 4.9760.9 5.4865.0 ,0.001*
CHD, N (%) 204 (25.6) 270 (22.2) 0.188 90 (33.7) 199 (42.4) 0.020*
Stroke, N (%) 111 (13.9) 144 (11.8) 0.172 29 (10.9) 67 (14.3) 0.181
The results are presented as mean 6 SD or N (%).
*statistically significant.
doi:10.1371/journal.pone.0100548.t001
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result in hypertension.
In the present study, the results suggested that these candidate
SNPs were significant genetic contributors to the phenotypes
among elderly, indicating that the associations of these SNPs with
MetS and metabolic-related traits observed in young population
are also able to be observed in elders. Advantages and limitations
of our study should be taken into account when interpreting the
findings. Our study has the advantage that subjects without
phenotypes were from old population, so the probability that they
will develop metabolic disorders in the future might be relatively
low. Therefore, the metabolic-related traits in older subjects may
faithfully reflect their genetic makeup. This hypothesis was also
mentioned in a study before [27]. However, our study also has
several limitations that subjects carrying certain genotypes
combined with the metabolic-related traits may not survive to
the old age, which may lead to biased conclusions of the
associations between these genotypes and the metabolic-related
traits among elderly. Participants were enrolled from communities
or streets in Wanshoulu area, which is a commodity-type
residential quarter where residents are usually with different
occupations and different backgrounds. The potential genetic bias
might be exist but is expected to be low. However, we could not
examine the extent of this bias. We conducted a longitudinal
analysis to further investigate the results from cross-sectional study,
but the small sample size limited our statistical power to detect
K+
G
C T
A
KCNQ1
G
C
T
A
ACE I
I
GPRH
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Figure 1. Functional associations between the SNPs and the phenotypes. The figure depicted the biological functional associations
between four SNPs and different traits of MetS. KCNQ1 (potassium voltage-gated channel KQT-like subfamily, member 1) is a gene encoding the
poreforming subunit of a voltage-gated K+ channel (KvLQT1) that plays a key role for the repolarization of the cardiac action potential as well as
water and salt transport in the beta cells. T allele variant might inhibit the KV-channels in beta cells and enhance glucose-stimulated insulin secretion,
which leads to an increased risk of diabetes. ACE gene encoding the angiotensin (Ang) and transform Ang I into Ang II, and the activation of Ang
IImight increase the storage of TG by influencing the glycolysis process and lead to the adipocyte hypertrophy. C allele variant of the INSIG2 gene was
involved in the reversed cholesterol transport by an interaction with sterol regulatory element-binding proteins (SREBPs), which are transcription
factors that activate the synthesis of cholesterol and fatty acids in the liver and other organs. In addition, A to C transition at nucleotide 1298 (A1298C,
rs1801131) of the coding sequence in gene MTHFR, have been shown to be the most frequent genetic causes for mild hyperhomocysteinemia, and a
high plasma concentration of homocysteine may predispose to atherosclerosis by injuring the vascular endothelium, which might result in
hypertension.
doi:10.1371/journal.pone.0100548.g001
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PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e100548these associations. Since the metabolic syndrome is highly complex
and polygenic, a large sample size would be needed.
Conclusions
In conclusion, among an elderly Chinese population, we found
statistically significant associations between SNP rs4402960 with
overweight and SNP rs1801131 with hypertension in cross-
sectional analyses. No statistically significant association was found
in longitudinal analyses, possibly due to the limited statistically
power. No SNP was found to be associated with MetS in our
analyses with statistically significance. Our findings suggest that
some of the SNPs identified among younger people are also
replicated in elderly. However, due to the limitations of our study,
further investigations on these associations are guaranteed.
Author Contributions
Conceived and designed the experiments: XYL LY YH. Performed the
experiments: JWL JL. Analyzed the data: JHY WYL. Wrote the paper:
JHY.
References
1. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus
Group (2005) The metabolic syndrome - a new worldwide definition. Lancet
366: 1059–1062.
2. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, et al. (1992)
Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes
41: 715–722
3. Isomaa B, Almgren P, Tuomi T, Forse ´n B, Lahti K, et al. (2001) Cardiovascular
morbidity and mortality associated with the metabolic syndrome. Diabetes Care
24: 683–689.
4. Bosy-Westphal A, Onur S, Geisler C, Wolf A, Korth O, et al. (2007) Common
familial influences on clustering of metabolic syndrome traits with central obesity
and insulin resistance: the Kiel obesity prevention study. Int J Obes (Lond) 31:
784–790.
5. Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, et al. (2008)
Prevalence and heritability of the metabolic syndrome and its individual
components in a Dutch isolate: the Erasmus Rucphen Family study. J Med
Genet 45: 572–577.
6. Bellia A, Giardina E, Lauro D, Tesauro M, Di Fede G, et al. (2009) The Linosa
Study: epidemiological and heritability data of the metabolic syndrome in a
Caucasian genetic isolate. Nutr Metab Cardiovasc Dis 19: 455–461.
7. He Y, Jiang Y, Wang J, Fan L, Li X, et al. (2006) Prevalence of peripheral
arterial disease and its association with smoking in a population-based study in
Beijing, China. J Vasc Surg 44:333–338.
8. The IDF consensus worldwide definition of the metabolic syndrome. Available:
http://wwwidforg/home/indexcfm?=unode=1120071E-AACE-41D2-9FA0-
BAB6E25BA072. Accessed 2005 Apr 14.
9. World Health Organization (2000). The Asia-Pacific perspective: redefining
obesity and its treatment. Geneva, Switzerland: World Health Organization.
10. World Health Organization (1999) Definition, Diagnosis and Classification of
Diabetes Mellitus and Its Complications: Reports of a WHO Consultation.
Geneva, World Health Org.
11. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve
type 2 diabetes susceptibility loci identified through large-scale association
analysis. Nat Genet 42: 579–589.
12. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, et al. (2009) Genetic
variant near IRS1 is associated with type 2 diabetes, insulin resistance and
hyperinsulinemia. Nat Genet 41: 1110–1111.
13. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, et al. (2009)
Confirmation of multiple risk Loci and genetic impacts by a genome-wide
association study of type 2 diabetes in the Japanese population. Diabetes 58:
1690–1699.
14. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, et
al. (2009) Genome-wide association yields new sequence variants at seven loci
that associate with measures of obesity. Nat Genet 41: 18–24.
15. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. (2009) Six new loci
associated with body mass index highlight a neuronal influence on body weight
regulation. Nat Genet 41: 25–34.
16. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenc ¸a C, Sparsø T, Holmkvist J, et
al. (2009) A variant near MTNR1B is associated with increased fasting plasma
glucose levels and type 2 diabetes risk. Nat Genet 41: 89–94.
17. Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, et al.
(2009) Adiposity-related heterogeneity in patterns of type 2 diabetes suscepti-
bility observed in genome-wide association data. Diabetes 58: 505–510.
18. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009)
Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77–81.
19. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, et al. (2008) Variants in
KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Net Genet
40: 1092–1097.
20. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-
analysis of genome-wide association data and large-scale replication identifies
additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638–645.
21. Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, et al. (2007) Type 2
diabetes whole-genome association study in four populations: the DiaGen
consortium. Am J Hum Genet 81: 338–345.
22. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and
triglyceride levels. Science 316: 1331–1336.
23. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-
wide association study of type 2 diabetes in Finns detects multiple susceptibility
variants. Science 316: 1341–1345.
24. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T,
et al. A variant in CDKAL1 influences insulin response and risk of type 2
diabetes. Net Genet 39: 770–775.
25. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007)
Replication of genome-wide association signals in UK samples reveals risk loci
for type 2 diabetes. Science 316: 1336–1341.
26. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007)
A common variant in the FTO gene is associated with body mass index and
predisposes to childhood and adult obesity. Science 316: 889–894.
27. Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, et al. (2007) Adiponectin
SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the
elderly. Am J Clin Nutr 86: 509–513.
28. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, et al.
(1999) A family of insulin-like growth factor II mRNA-binding proteins represses
translation in late development. Mol Cell Biol 19:1262–1270.
29. Rong R, Hanson RL, Ortiz D, Wiedrich C, Kobes S, et al. (2009) Association
analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2,
IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related
quantitative traits in Pima Indians. Diabetes 58: 478–488.
30. Li X, Allayee H, Xiang AH, Trigo E, Hartiala J, et al. (2009) Variation in
IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican
Americans, Obesity 17:729–736.
31. Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, et al. (2008) SNPs
in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and
European populations. Nat Genet 40: 1098–1102.
32. Yu W, Ma RC, Hu C, So WY, Zhang R, et al. (2012) Association between
KCNQ1 genetic variants and obesity in Chinese patients with type 2 diabetes.
Diabetologia 55:2655–2659.
33. Hu C, Wang C, Zhang R, Ma X, Wang J, et al. (2009) Variations in KCNQ1
are associated with type 2 diabetes and beta cell function in a Chinese
population. Diabetologia 52: 1322–1325.
34. Liu Y, Zhou DZ, Zhang D, Chen Z, Zhao T, et al. (2009) Variants in KCNQ1
are associated with susceptibility to type 2 diabetes in the population of mainland
China. Diabetologia 52: 1315–1321.
35. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, et al. (1996)
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause
cardiac arrhythmias. Nat Genet 12: 17–23.
36. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, et al. (1997) A novel
mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-
Nielsen cardioauditory syndrome. Nat Genet 15: 186–189.
37. MacDonald PE, Ha XF, Wang J, Smukler SR, Sun AM, et al. (2001) Members
of the Kv1 and Kv2 Voltage-Dependent K+ Channel Families Regulate Insulin
Secretion. Mol Endocrinol 15: 1423–1435.
38. MacDonald PE, Sewing S, Wang J, Joseph JW, Smukler SR, et al. (2002)
Inhibition of Kv2.1 Voltage-dependent K+ Channels in Pancreatic beta –Cells
Enhances Glucose-dependent Insulin Secretion. J Biol Chem 277: 44938–44945.
39. Zhang M, Houamed K, Kupershmidt S, Roden D, Satin LS (2005)
Pharmacological Properties and Functional Role of Kslow Current in Mouse
Pancreatic {beta}-Cells: SK Channels Contribute to Kslow Tail Current and
Modulate Insulin Secretion. J Gen Physiol 126: 353–363.
40. Groenewoud MJ, Dekker JM, Fritsche A, Reiling E, Nijpels G, et al. (2008)
Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during
hyperglycaemic clamps. Diabetologia 51:1659–1663.
41. Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, et al. (2008)
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from
whole genome association studies in the Insulin Resistance Atherosclerosis
Family Study. Diabetes 57:1093–1100
42. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, et al. (2006)A
common genetic variant is associated with adult and childhood obesity. Science
312: 279–283.
Genetic Effects on Metabolism in Chinese Elders
PLOS ONE | www.plosone.org 7 June 2014 | Volume 9 | Issue 6 | e10054843. Yabe D, Brown MS, Goldstein JL (2002) Insig-2, a second endoplasmic
reticulum protein that binds SCAP and blocks export of sterol regulatory
element-binding proteins. Proc Natl Acad Sci USA 99: 12753–12758.
44. Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS (2003) Liver-specific
mRNA for Insig-2 down-regulated by insulin: implications for fatty acid
synthesis. Proc Natl Acad Sci USA 100: 3155–3160.
45. Dina C, Meyre D, Samson C, Tichet J, Marre M, et al. (2007) Comment on ‘‘A
common genetic variant is associated with adult and childhood obesity’’. Science
315: 187.
46. Loos RJ, Barroso I, O’rahilly S, Wareham NJ (2007) Comment on’’A common
genetic variant is associated with adult and childhood obesity’’. Science 315:
187.
47. Rosskopf D, Bornhorst A, Rimmbach C, Schwahn C, Kayser A, et al. (2007)
Comment on ‘‘A common genetic variant is associated with adult and childhood
obesity’’. Science 315: 187.
48. Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, et al. (2007)
Association between the 2455T.C promoter polymorphism of the APOC3
gene and the metabolic syndrome in a multi-ethnic sample. BMC Med Genet 8:
80.
49. Ciullo M, Nutile T, Dalmasso C, Sorice R, Bellenguez C, et al. (2008)
Identification and replication of a novel obesity locus on chromosome 1q24 in
isolated populations of Cilento. Diabetes 57: 783–790.
50. Kumar J, Sunkishala RR, Karthikeyan G, Sengupta S (2007) The common
genetic variant upstream of INSIG2 gene is not associated with obesity in Indian
population. Clin Genet 71: 415–418.
51. Smith AJ, Cooper JA, Li LK, Humphries SE (2007) INSIG2 gene polymorphism
is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects.
Int J Obes (Lond) 31: 1753–1755.
52. Boes E, Kollerits B, Heid IM, Hunt SC, Pichler M, et al. (2008) INSIG2
Polymorphism Is Neither Associated With BMI Nor With Phenotypes of
Lipoprotein Metabolism. Obesity (Silver Spring) 16: 827–833.
53. Oki K, Yamane K, Kamei N, Asao T, Awaya T, et al. (2009) The single
nucleotide polymorphism upstream of insulin-induced gene 2 (INSIG2) is
associated with the prevalence of hypercholesterolaemia, but not with obesity, in
Japanese American women. Br J Nutr 101: 322–327.
54. Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, et al. (2007) MTHFR
677 CT/MTHFR 1298 CC genotypes are associated with increased risk of
hypertension in Indians. Mol Cell Biochem 302: 125–131.
55. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. (1995) A candidate
genetic risk factor for vascular disease: a common mutation in methylenete-
trahydrofolate reductase. Nat Genet 10: 111–113.
56. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic
polymorphism in methyltetrahydrofolate reductase (MTHFR) associated with
decreased enzyme activity. Mol Genet Metab 64: 169–172.
Genetic Effects on Metabolism in Chinese Elders
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e100548